Fig. 2From: Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failureResults for secondary end points show a significant decrease in LAVI and LVMI significant decreased 6 months after administration of dapagliflozin. No significant change was observed in BNP 6 months after administration of dapagliflozinBack to article page